Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis

INTRODUCTION: Warfarin and new oral anticoagulants are effective in reducing stroke in atrial fibrillation; however, the benefits and risks rates in clinical trials show heterogeneity for each anticoagulant, and is unknown the cost influence on a model considering most of the treatment consequences....

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza-Sanchez, Jose, Silva, Federico, Rangel, Lady, Jaramillo, Linda, Mendoza, Leidy, Garzon, Jenny, Quiroga, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933763/
https://www.ncbi.nlm.nih.gov/pubmed/29723207
http://dx.doi.org/10.1371/journal.pone.0196361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933763/
https://www.ncbi.nlm.nih.gov/pubmed/29723207
http://dx.doi.org/10.1371/journal.pone.0196361

Ejemplares similares